ArticleMolecular pharmaceutics2015

CD19-Targeted Nanodelivery of Doxorubicin Enhances Therapeutic Efficacy in B-Cell Acute Lymphoblastic Leukemia.

Vinu Krishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.